No Data
No Data
Minsheng Health (301507.SZ): Net profit of 58.7723 million yuan in the first quarter increased by 6.51% year-on-year
On April 23, Ge Longhui | Minsheng Health (301507.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 235 million yuan, up 5.78% year on year; net profit attributable to shareholders of listed companies was 588.723 million yuan, up 6.51% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 57.0676 million yuan, up 3.95% year on year; basic earnings per share were 0.1,700 yuan.
Minsheng Health (301507.SZ): Focus on the field of vitamin and mineral supplements
Gelonghui, April 17 | Minsheng Health (301507.SZ) said on the investor interactive platform that the company focuses on the field of vitamin and mineral supplements, and currently sells mainly vitamin and mineral supplement series products.
Minsheng Health (301507.SZ): The ban on 4.593 million restricted shares will be lifted on March 5
Gelonghui, February 28, 丨 Minsheng Health (301507.SZ) announced an indicative announcement on the listing and circulation of restricted shares for the initial public offering. The total number of shareholders whose sales restrictions have been lifted is 6,951, and the number of shares that have been lifted is 4,593 million shares, accounting for 1.29% of the company's total share capital. The sales restriction period is 6 months from the date of the company's initial public offering and listing. The stock listing and circulation date for which sales restrictions have been lifted is March 5, 2024 (Tuesday).
Minsheng Health (301507.SZ): 2023 net profit pre-increased 6.35%-11.42%
Gelonghui, January 15, 丨 Minsheng Health (301,507.SZ) announced its 2023 annual results forecast, with operating income of 58,000,000 yuan to 60,000,000 yuan, an increase of 6.01% to 9.67% over the same period of the previous year; net profit attributable to shareholders of listed companies was 84.0 million yuan - 88.0 million yuan, an increase of 6.35% to 11.42% over the same period of the previous year; net profit profit after deducting non-recurring profit and loss of 74.0 million yuan to 80.2 million yuan over the same period of the previous year 5.28% —16.66
People's Livelihood and Health (301507.SZ): The probiotic series has now been mass-produced
Glonghui, December 25|Some investors asked Minsheng Health (301507.SZ) on the investor interactive platform, “Is the probiotic series now mass-produced?” The company replied that the company's probiotic series has now been mass-produced and is produced and sold through Zhejiang Minsheng Health Technology Co., Ltd., a wholly-owned subsidiary.
Minsheng Health (301507.SZ): A business partnership with Ali Health Pharmacy
Glonghui December 7: Some investors asked Minsheng Health (301507.SZ) on the investor interactive platform, “Does the company cooperate with Ali Health?” The company replied that the company has a business partnership with Ali Health Pharmacy. The company won the “Ali Health Pharmacy Reputation Brand of the Year” and the “Ali Health Golden Deer Award” in 2020, the “Ali Health Golden Deer Award - Best Reputation Award” in 2021, and the “Ali Health Golden Deer Award - Innovative Brand Award” in 2022.
No Data